Sec. 309. Improvements to transparency of the pricing of diagnostic testing for COVID–19
420 words·~2 min read·
/bill/116/s/4800/pcs/section-309A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 3202 of the CARES Act ( Public Law 116–136 ) is amended— in subsection (b)— in the heading, by inserting after and related items and services ; diagnostic testing for COVID–19 in paragraph (1)— by striking a diagnostic test for COVID–19 and inserting a test, item, or service described in section 6001(a) of division F of the Families First Coronavirus Response Act ; and by striking such test and inserting such test, item, or service ; and in paragraph (2), by striking a diagnostic test for COVID–19 and inserting a test, item, or service described in section 6001(a) of division F of the Families First Coronavirus Response Act ; and by adding at the end the following new subsections:
Not later than 30 days after the date of the enactment of this subsection, the Secretary of Health and Human Services shall conduct a survey of providers of the items and services described in section 6001(a) of division F of the Families First Coronavirus Response Act (Public Law 116– 127) regarding the cash prices for such items and services listed by the providers on a public internet website of such provider. In carrying out paragraph (1), the Secretary shall survey a sample of providers that is representative of the diversity of sizes, geographic locations, and care settings (such as hospitals, laboratories, and independent freestanding emergency department) in which diagnostic testing for COVID–19 is performed.
Not later than 60 days after the date of the enactment of this subsection, the Secretary of Health and Human Services shall publish on the Internet website of the Department of Health and Human Services a report on cash prices for items and services published under subsection (b)(1) during the period beginning on the date of the enactment of this Act and ending on the date of the enactment of this subsection, which shall include— the percentage of providers that comply with the publication requirement under such subsection; the average cash price for each item and service described in section 6001(a) of division F of the Families First Coronavirus Response Act that is published under such subsection; with respect to each such item and service, a comparison of such average cash price to the reimbursement rate under the Medicare program under title XVIII of the Social Security Act ( 42 U.S.C. 1395 et seq.); and any cash prices published under such subsection that substantially exceed the average cash price for each such item or service and the name of each provider that charges such prices. .
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Sec. 309
Improvements to transparency of the pricing of diagnostic testing for COVID–19
Cites 2Cited by 0 across 0 sources